Edition:
United States

Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

960.75INR
25 Jul 2017
Change (% chg)

-- (--)
Prev Close
Rs960.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
19,799
52-wk High
Rs1,145.00
52-wk Low
Rs902.05

Latest Key Developments (Source: Significant Developments)

Astrazeneca Pharma India appoints Gagan Singh Bedi as MD of co
Thursday, 29 Jun 2017 07:16am EDT 

June 29 (Reuters) - Astrazeneca Pharma India Ltd :Says Sanjay Murdeshwar has offered to resign as managing director of company.Says board has accepted Murdeshwar's resignation.Says board co-opted Gagan Singh Bedi as additional director, who will take over as MD of co with effect from July 1, 2017.  Full Article

Astrazeneca Pharma India gets import and market permission from DCGI for FDC of asthma drug
Thursday, 15 Jun 2017 08:27am EDT 

June 15 (Reuters) - Astrazeneca Pharma India Ltd ::Received import and market permission in form 45 from DCGI (Drug Controller General of India)for FDC of Budesonide 320 μg + Formoterol Fumarate Dihydrate 9 μg inhalation powder.Says drug indicated for treatment of asthma.  Full Article

Astrazeneca Pharma India posts March-qtr loss
Tuesday, 9 May 2017 08:04am EDT 

May 9 (Reuters) - Astrazeneca Pharma India Ltd :March quarter net loss 28.8 million rupees.March quarter total income from operations 1.12 billion rupees.Net profit in March quarter last year was 5.6 million rupees; total income from operations was 1.59 billion rupees.  Full Article

Pfizer enters into delegation of authority with Astrazeneca Pharma India
Wednesday, 18 Jan 2017 07:49am EST 

Pfizer Ltd : Pfizer Ltd says entered into delegation of authority with Astrazeneca Pharma India . Pfizer Ltd says Meronem IV injection, currently marketed in India by Astrazeneca, is expected to be transitioned to co .Pfizer Ltd - co granted authority for pricing and reimbursement talks, promotional, marketing, tendering and bidding for injectable antibiotic products.  Full Article

Astrazeneca Pharma India March-qtr profit falls
Wednesday, 25 May 2016 06:06am EDT 

Astrazeneca Pharma India Ltd : Says March-quarter net profit 5.6 million rupees; March-quarter net sales 1.34 billion rupees .  Full Article

BRIEF-Astrazeneca Pharma India appoints Gagan Singh Bedi as MD of co

* Says Sanjay Murdeshwar has offered to resign as managing director of company

No consensus analysis data available.